PIOMBINO DESE, Italy (BUSINESS WIRE) Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
- Reiterates Full Year 2023 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
Q1 2023 Financial Highlights Record quarterly revenue of $1.2 billion, representing a 24% increase year-over-yearRecord quarterly organic revenue growth of 12% driven by strength in both. | May 3, 2023
FORT WORTH, Texas, April 27, 2023 FirstCash Holdings, Inc. , the leading international operator of retail pawn stores and a leading provider of retail point-of-sale payment solutions, today. | April 27, 2023